Zheng Quan Shi Bao Wang·2025-10-19 23:47Core Insights - New Lotus has submitted a listing application to the Hong Kong Stock Exchange, with GF Securities (Hong Kong) and Agricultural Bank of China International as joint sponsors [1] Company Overview - New Lotus ranks second in the Chinese market for traditional Chinese medicine (TCM) decoction pieces, with a market share of 0.4% [1] - The company is the fastest-growing among the top five participants, with a compound annual growth rate (CAGR) of 27% in revenue from 2022 to 2024 [1] Business Strategy - The company employs a dual-pillar strategy, serving hospital and chain pharmacy clients through offline channels while expanding into the retail market with consumer health products [1] Market Potential - The TCM decoction piece market is large and rapidly growing, with New Lotus offering over 770 types and 4,900 categories of products [1]